Differential optical densities of intraretinal spaces.
暂无分享,去创建一个
[1] William J Feuer,et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2007, American journal of ophthalmology.
[2] D. Hunt,et al. The cone dysfunction syndromes , 2004, British Journal of Ophthalmology.
[3] F. Munier,et al. Cross-sectional study of visual acuity and electroretinogram in two types of dominant drusen. , 2003, Investigative ophthalmology & visual science.
[4] Alain Gaudric,et al. Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. , 2006, Archives of ophthalmology.
[5] P. Charbel Issa,et al. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. , 2007, Ophthalmology.
[6] Ali Erginay,et al. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. , 2003, American journal of ophthalmology.
[7] V. Gabel,et al. Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[8] B. Blodi,et al. Idiopathic juxtafoveolar retinal telangiectasis , 1993 .
[9] Wolfgang Drexler,et al. Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography. , 2006, Ophthalmology.
[10] A. Moore,et al. The cone dystrophies , 1998, Eye.
[11] F. Sutter,et al. Quantitative analysis of OCT characteristics in patients with achromatopsia and blue-cone monochromatism. , 2006, Investigative ophthalmology & visual science.
[12] S. Mennel,et al. [Treatment of idiopathic juxtafoveolar retinal telangiectasis with bevacizumab (avastin)]. , 2007, Klinische Monatsblatter fur Augenheilkunde.
[13] M. Marmor,et al. Standard for clinical electroretinography (1999 update) , 1998, Documenta Ophthalmologica.
[14] Steven M. Cohen,et al. OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN NONPROLIFERATIVE GROUP 2A IDIOPATHIC JUXTAFOVEAL RETINAL TELANGIECTASIS , 2007, Retina.
[15] J. Gass,et al. Müller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacualr retinoschisis. , 1999, Archives of ophthalmology.
[16] M. Farah,et al. Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa. , 2007, Acta ophthalmologica Scandinavica.
[17] G. Yancopoulos,et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. , 2001, Investigative ophthalmology & visual science.
[18] J. Gass,et al. Idiopathic juxtafoveolar retinal telangiectasis. , 1982, Archives of ophthalmology.
[19] W R Green,et al. Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization. , 1995, Histology and histopathology.
[20] L. Yannuzzi,et al. Idiopathic Macular Telangiectasia , 2006, Retina.
[21] J. Flammer,et al. [Circulatory disorders of the choroid in patients with central serious chorioretinopathy]. , 1996, Klinische Monatsblatter fur Augenheilkunde.
[22] H. Koizumi,et al. Morphologic features of group 2A idiopathic juxtafoveolar retinal telangiectasis in three-dimensional optical coherence tomography. , 2006, American journal of ophthalmology.
[23] J. Flammer,et al. Choroidal capillary and venous congestion in central serous chorioretinopathy. , 1996, American journal of ophthalmology.